tizanidine has been researched along with Myalgia in 1 studies
tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
Myalgia: Painful sensation in the muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A strong need exists for the development of transdermal patch having improved bioavailability at the site of action with fewer side effects at off-target organs." | 1.48 | Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. ( Katas, H; Rahman, KU; Razzaq, Z; Shahid, N; Siddique, MI; Waqas, MK, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shahid, N | 1 |
| Siddique, MI | 1 |
| Razzaq, Z | 1 |
| Katas, H | 1 |
| Waqas, MK | 1 |
| Rahman, KU | 1 |
1 other study available for tizanidine and Myalgia
| Article | Year |
|---|---|
Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Topics: Administration, Cutaneous; Animals; Biological Availability; Clonidine; Delayed-Action Preparations; | 2018 |